DEXAMETHASONE

More in DEXAMETHASONE

• Early Covid treatments could be a ‘bridge’ to vaccine

  Antibody-based medications, other blood products from recovered patients and antivirals are being investigated as early treatments, Fauci said.

  

• Kochi-based company to start phase 2b trials of COVID drug next week

  PNB Vesper Life’s chief executive PN Balaram is upbeat the company’s experimental drug PNB-001 will be effective in treating symptoms of Covid-19. The Kochi-based pharma company is set to begin clinical trials on patients suffering from the disease next week.

  

• Regeneron's antibody drug added to UK Recovery trial of Covid treatments

  So far, 92 lower-income nations are seeking assistance via the COVAX facility, part of the WHO's ACT Accelerator to boost development of vaccines, therapeutics and diagnostics to combat the pandemic. Some 80 higher-income nations have expressed interest, but many must still confirm their intention to join by the end of this week.

  

• New Covid-19 drug gets DCGI's nod for human trial

  Speaking to IANS about the breakthrough innovation, CEO of PNB Vesper Life Science Private Limited P.N. Balaram said that this is a very big step for mankind in the fight against the Covid-19 pandemic.

  

• Activated form of vitamin D reduced severity of Covid infection: Study in Spain

  The finding comes as the search intensifies for new antiviral, re-purposed and cheap drugs to treat patients with severe Covid-19.

  

• Steroids cut death rates among critically ill Covid-19 patients, major study finds

  Treating critically ill Covid-19 patients with corticosteroid drugs reduces the risk of death by 20%, an analysis of seven international trials found on Wednesday, prompting the World Health Organisation to update its advice on treatment.

  

• Finland rations paracetamol over supply fears

  The sale of some commonly used medicines will be restricted in Finland in order to ensure enough availability during the next predicted coronavirus wave, the health ministry announced on Tuesday.

  

• WHO-sponsored plan for new Covid-19 tools has shown results: Tedros

  Speaking at a virtual press conference from Geneva on Thursday, the WHO chief said the plan, named Access to Covid-19 Tools ACT-Accelerator and started in April, has come out with nine vaccine candidates that are going through Phase 2 or 3 trials, Xinhua news agency reported.

  

• Dr. Reddy's Laboratories announces the First-to-Market launch of the generic version of Ciprodex in US

  Ciprofloxacin 0.3% and dexamethasone 0.1% otic suspension is indicated for the treatment of infections caused by susceptible isolates of the designated microorganisms in the specific conditions of Acute Otitis Media (AOM) in pediatric and Acute Otitis Externa (AOE) in pediatric, adult and elderly patients.

  

• Rival drugmakers launch joint trial of medicines for covid-19

  The covid-19 pandemic is an "all hands on deck moment," David Reese, Amgen's research and development chief told Reuters. "We wanted a trial to be able to quickly sift through multiple agents and prioritize."

  

• New studies clarify what drugs help, hurt for COVID-19

  Fresh studies give more information about what treatments do or don't work for COVID-19, with high-quality methods that give reliable results.